We’ve picked our favourite papers and articles about development of the year, picking pieces that help us understand the problems we’re working on better and how best to fix them.
CGD Policy Blogs
At a recent CGD staff presentation of our work into COVID-19 vaccines, our colleagues raised a large number of interesting questions, so, we asked our colleagues to send in their questions on the COVID-19 vaccine portfolio.
New research by Refugees International and the Center for Global Development (CGD) finds that Venezuelans in Peru face major barriers that prevent them from integrating into the Peruvian economy. As a result, many are pushed into informal, low-paying jobs that do not match their qualifications. Some are subjected to exploitation and abuse. And because of these factors, Venezuelans are more vulnerable to economic shocks, such as COVID-19.
Given that international travelers introduced COVID-19 to almost every country in the world, it's natural to associate international mobility with the spread of disease. During the pandemic, 179 countries have implemented some form of travel restrictions. And beyond COVID-19, some countries may uphold such restrictions for fear of the next pandemic.
Did you know that Zimbabwe is one of four low- and lower-middle-income countries (LICs and LMCs) where a severe economic contraction in 2020 combines with very low levels of women’s wellbeing and low capacity of the state to target government payments and other social assistance to women and girls?
Can technology help? At the most basic level, a COVID ID would be a digitized version of the Yellow Card, the paper-based International Certificate of Vaccination or Prophylaxis that many international travelers carry with them traveling to and from high-risk areas of the world.
CGD and Georgetown University’s Initiative on Innovation, Development and Evaluation (gui2de) are collaborating on a new seminar series called The Future of Development.
Since the start of the pandemic, I have been collaborating with Amber Peterman and other researchers to improve understanding of how pandemics and other crises increase the likelihood of violence against women, track a growing evidence base focused on rates of VAW in the COVID context, and propose solutions for how donor institutions and policymakers should respond to this shadow pandemic and prevent a return to a pre-COVID-19 “normal.
Today we launch an interactive tool that analyses the COVID-19 vaccine portfolio, and generates estimates about the timelines for the vaccines in the portfolio.
Yesterday, Pfizer/BNTech issued a press release on the status of their COVID-19 vaccine candidate that is encouraging. However, in addition to the three concerns specific to resource-constrained settings that my colleague Rachel Silverman shared yesterday, cheering is probably not (yet) in order in wealthier countries either.